• SENSEX 81,024.30
    -426.71 (--0.52%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Niva Bupa Health
    82.00 61.01(%)
  • Reliance Power
    62.80 60.50(%)
  • Max Healthcare
    1,156.00 1,227.50(%)
  • Mazagon Dock
    3,380.35 1,200.00(%)
  • Garden Reach Sh.
    2,875.00 1,148.10(%)
  • Suzlon Energy
    73.44 86.04(%)
  • Yes Bank
    22.86 27.41(%)
  • St Bk of India
    817.70 912.10(%)
  • Inox Wind
    190.40 124.35(%)
  • Reliance Infra.
    346.80 350.90(%)
  • Cochin Shipyard
    1,900.55 1,180.45(%)
  • SG Finserve
    445.95 546.00(%)
  • Bharat Dynamics
    1,965.00 897.15(%)
  • Eternal Ltd
    241.85 304.50(%)
  • MMTC
    77.57 42.55(%)
  • Data Pattern
    2,967.45 3,654.75(%)
  • Reliance Industr
    1,395.90 1,115.55(%)
  • Bank of Maha
    57.42 73.50(%)
  • Canara Bank
    116.80 129.35(%)
  • Titagarh Rail
    910.00 1,896.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

BDH Industries Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4720.0
  • ISIN : INE278D01018
247.95 -4 (-1.49%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    247.25

  • Today’s High

    251.95

  • Open

    250.00

  • Perv Close

    251.70

  • 52W Low

    241.00

  • 52W High

    417.85

Key Indicators

  • P/E(TTM)

    15.40

  • Mar.Cap (₹Cr.)

    142.82

  • Div & Yield %

    1.81

  • Book Value(₹)

    117.08

  • Debt-Equity Ratio

    -1.49

  • AGM Date

    30-May-2025

  • EPS

    16.10

  • P/E Ratio

    15.40

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    142.82

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.76

  • BV (₹)

    117.10

  • Sales( ₹ in Cr.)

    66.51

  • NP (in Cr.)

    9.27

  • NP Var(%)

    -6.0

  • Div%

    45.0

  • CPS (₹)

    17.70

  • EPS (₹)

    16.10

  • Traded Value (₹ in Lakhs)

    142.82

  • 52 Week High

    417.85

  • 52 Week Low

    241.00

  • Price BSE

    248.0

  • Price NSE

    1.00

  • Market Capital( in Cr.)

    142.82

  • P/C Ratio

    14.00

  • P/E Ratio

    15.40

  • Price Vs.BV

    16.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 85.83 74.46 69.39 57.45 59.48 51.69
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 85.83 74.46 69.39 57.45 59.48 51.69
Other Income 1.58 0.84 1.33 1.30 0.80 0.89
Stock Adjustments -0.61 -1.89 0.55 1.17 -0.89 -0.07
Total Income 86.80 73.41 71.27 59.92 59.39 52.51
EXPENDITURE :            
Raw Materials 59.66 47.80 49.53 38.35 35.26 31.56
Power and Fuel Cost 1.78 1.74 1.41 1.49 2.29 2.13
Employee Cost 7.43 6.96 6.62 6.26 7.50 6.77
Other Manufacturing Expenses 0.62 0.86 0.43 0.97 1.44 1.30
Selling and Administration Expenses 3.10 4.09 2.67 2.84 2.84 2.69
Miscellaneous Expenses 0.19 0.18 0.21 0.20 0.28 0.17
Employee Benefit Expenses 7.43 6.96 6.62 6.26 7.50 6.77
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 72.79 61.62 60.87 50.11 49.61 44.61
Operating Profit 14.01 11.80 10.42 9.81 9.77 7.89
Interest 0.18 0.16 0.23 0.28 0.69 0.52
Gross Profit 13.83 11.64 10.19 9.53 9.08 7.37
Depreciation 0.57 0.57 0.63 0.79 0.96 0.83
Profit Before Tax 13.26 11.07 9.56 8.74 8.12 6.54
Current Tax 2.94 2.87 2.33 2.45 2.27 1.59
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.44 -0.01 0.00 -0.06 -0.10 0.13
Reported Net Profit 9.87 8.20 7.22 6.36 5.94 4.83
Extraordinary Items 0.00 0.00 0.34 0.00 0.00 0.00
Adjusted Net Profit 9.87 8.20 6.88 6.36 5.94 4.83
Adjustment below Net Profit -0.10 -0.01 0.04 -0.08 -0.45 -0.44
P & L Balance brought forward 34.54 29.65 25.20 21.31 18.29 15.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.76 3.30 2.81 2.39 2.47 2.02
P & L Balance carried down 40.55 34.54 29.65 25.20 21.31 18.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 45.00 40.00 36.00 30.00 25.00 27.50
Dividend Per Share(Rs) 4.50 4.00 3.60 3.00 2.50 2.75
Earnings Per Share-Unit Curr 17.14 14.25 12.55 10.71 10.01 8.13
Earnings Per Share(Adj)-Unit Curr 17.14 14.25 12.55 10.71 10.01 8.13
Book Value 105.67 92.71 82.07 70.24 62.09 55.50
Book Value(Adj)-Unit Curr 105.67 92.71 82.07 70.24 62.09 55.50

Shareholding Pattern

  • Promoter Group

    49.66%

  • Public Share Holding

    50.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 464,380 464,380.00 464,380 464,380
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 464,380 8.07 464,380 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,394,868 41.60 2,394,268 18
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,394,868 41.60 2,394,268 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,024 0.28 16,024 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,024 0.28 16,024 1
2] Non Institution
Bodies Corporate 334,473 5.81 334,373 28
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 88,213 1.53 88,213 87
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 199,530 3.47 199,530 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 144,142 2.50 144,142 5
Individuals holding nominal share capital up to Rs. 1 lakh 1,526,370 26.51 1,443,570 4,760
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 589,300 10.24 589,300 101
Sub Total 2,882,028 50.06 2,799,128 4,982
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,757,300 100.00 5,673,800 5,002

Company Background

BDH Industries LtdPharmaceuticals - Indian - Formulations

  • BDH Industries Ltd
  • BSE Code : 4720.0
  • ISIN : INE278D01018

  • Incorporation Year

    1990

  • Registered Office

    Nair Baug
    Akurli Road Kandivli (E), Mumbai,
    Maharashtra-400101

  • Telephone

    91-22-28871370/28870834

  • FAX

    91-22-28868349

  • Chairman

    Jayashree Nair

  • Managing Director

    S C Kachhara

  • Company Secretary

    Nikita Phatak

  • Auditor

    CLB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

BDH Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
BDH Industries 247.95 87.41 85.83 15.40 20.89
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92